global corporate venturing: healthcare innovation
TRANSCRIPT
![Page 1: Global Corporate Venturing: Healthcare Innovation](https://reader038.vdocuments.mx/reader038/viewer/2022110210/56649eb65503460f94bbff56/html5/thumbnails/1.jpg)
Global Corporate Venturing: Healthcare Innovation
![Page 2: Global Corporate Venturing: Healthcare Innovation](https://reader038.vdocuments.mx/reader038/viewer/2022110210/56649eb65503460f94bbff56/html5/thumbnails/2.jpg)
Penetration of CVC by Industry
Source: BCG, October 2012, analysing Global Corporate Venturing’s data
![Page 3: Global Corporate Venturing: Healthcare Innovation](https://reader038.vdocuments.mx/reader038/viewer/2022110210/56649eb65503460f94bbff56/html5/thumbnails/3.jpg)
![Page 4: Global Corporate Venturing: Healthcare Innovation](https://reader038.vdocuments.mx/reader038/viewer/2022110210/56649eb65503460f94bbff56/html5/thumbnails/4.jpg)
New health funds and commitments
• GSK’s $50m bioelectronic fund and LP commitment to Kurma Biofund II
• Stanford-StartX• Cipla incubator• BI joins Rockspring• Amgen and Novartis partner with Atlas• Bayer and Roche to QB3• MS Ventures doubles to €100m• Quintiles’ NovaQuestSource: Sample selected www.GlobalCorporat Venturing.com in 2013
![Page 5: Global Corporate Venturing: Healthcare Innovation](https://reader038.vdocuments.mx/reader038/viewer/2022110210/56649eb65503460f94bbff56/html5/thumbnails/5.jpg)
Q2 Fundraising and Trends
ParentCorporate Venturing Unit/Fund Size Parent's Region Sector
TataTata Opportunities Fund $600m Asia Industrial
Unilever Unllever Ventures $450m Europe Consumer
SAP Hana Fund $250m* Europe IT
ShellShell Technology Ventures $100ms* Europe Energy
Merck MS Ventures €100m* Europe Health
Grupo RBS e.Bricks Digital $100m RoW IT
Infosys Fund $100m Asia IT
Giant Interactive Group Pleb Dream Fund RMB1bn ($161m) Asia Media
Intel Perceptual fund $100m US IT
Quintiles NovaQuest $80m US Health
Source: Global Corporate Venturing* expansion of existing fund
![Page 6: Global Corporate Venturing: Healthcare Innovation](https://reader038.vdocuments.mx/reader038/viewer/2022110210/56649eb65503460f94bbff56/html5/thumbnails/6.jpg)
![Page 7: Global Corporate Venturing: Healthcare Innovation](https://reader038.vdocuments.mx/reader038/viewer/2022110210/56649eb65503460f94bbff56/html5/thumbnails/7.jpg)
Healthcare CVC’s narcissism
Source: BCG, October 2012, analysing Global Corporate Venturing’s 1,300 deals
![Page 8: Global Corporate Venturing: Healthcare Innovation](https://reader038.vdocuments.mx/reader038/viewer/2022110210/56649eb65503460f94bbff56/html5/thumbnails/8.jpg)
Source: Global
Corporate Venturing
![Page 9: Global Corporate Venturing: Healthcare Innovation](https://reader038.vdocuments.mx/reader038/viewer/2022110210/56649eb65503460f94bbff56/html5/thumbnails/9.jpg)
2011-13 Deal
Activity
Source: Global Corporate Venturing
![Page 10: Global Corporate Venturing: Healthcare Innovation](https://reader038.vdocuments.mx/reader038/viewer/2022110210/56649eb65503460f94bbff56/html5/thumbnails/10.jpg)
Q2 2013 activity
Source: Global Corporate Venturing
![Page 11: Global Corporate Venturing: Healthcare Innovation](https://reader038.vdocuments.mx/reader038/viewer/2022110210/56649eb65503460f94bbff56/html5/thumbnails/11.jpg)
Q2 Deal Activity
• 246 investments worth $5bn• 40 exits – IPOs picking up by number• M&A from portfolio companies up by a third• Series A leads by number of deals• IT most active, healthcare rebounds,• Asia and Europe increasing but US leads
![Page 12: Global Corporate Venturing: Healthcare Innovation](https://reader038.vdocuments.mx/reader038/viewer/2022110210/56649eb65503460f94bbff56/html5/thumbnails/12.jpg)
“A global, multimedia publishing group dedicated to serving the intermediaries directing funding to entrepreneurs in the innovation
economy.”
Contact: James Mawson, founder and editor-in-chief [email protected]+1 650 906 1356 (US main) or +44 (0) 7971655590 (UK)